• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

流感保护性免疫的动态在年龄特异性方面的差异。

Age-specific differences in the dynamics of protective immunity to influenza.

机构信息

Department of Ecology and Evolution, University of Chicago, 1101 E 57th Street, Chicago, IL, 60637, USA.

WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, The University of Hong Kong, Patrick Manson Building, 7 Sassoon Road, Pokfulam, Hong Kong, China.

出版信息

Nat Commun. 2019 Apr 10;10(1):1660. doi: 10.1038/s41467-019-09652-6.

DOI:10.1038/s41467-019-09652-6
PMID:30971703
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6458119/
Abstract

Influenza A viruses evolve rapidly to escape host immunity, causing reinfection. The form and duration of protection after each influenza virus infection are poorly understood. We quantify the dynamics of protective immunity by fitting individual-level mechanistic models to longitudinal serology from children and adults. We find that most protection in children but not adults correlates with antibody titers to the hemagglutinin surface protein. Protection against circulating strains wanes to half of peak levels 3.5-7 years after infection in both age groups, and wanes faster against influenza A(H3N2) than A(H1N1)pdm09. Protection against H3N2 lasts longer in adults than in children. Our results suggest that influenza antibody responses shift focus with age from the mutable hemagglutinin head to other epitopes, consistent with the theory of original antigenic sin, and might affect protection. Imprinting, or primary infection with a subtype, has modest to no effect on the risk of non-medically attended infections in adults.

摘要

甲型流感病毒迅速进化以逃避宿主免疫,导致再次感染。每次感染流感病毒后,保护的形式和持续时间尚不清楚。我们通过将个体水平的机械模型拟合到儿童和成人的纵向血清学数据,来量化保护性免疫的动态。我们发现,大多数保护作用(儿童中)但不是(成人中)与针对血凝素表面蛋白的抗体滴度相关。在感染后 3.5-7 年内,两组人群对流行株的保护作用均衰减至峰值水平的一半,而且对 A(H3N2)的衰减速度快于 A(H1N1)pdm09。成人对 H3N2 的保护作用比儿童更长。我们的研究结果表明,流感抗体反应随着年龄的增长而从易变的血凝素头部转移到其他表位,这与原始抗原性理论一致,并且可能影响保护作用。印迹(或亚株的初次感染)对成人非医疗相关感染的风险几乎没有影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd3e/6458119/9aa9e553cb1c/41467_2019_9652_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd3e/6458119/3764e6238308/41467_2019_9652_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd3e/6458119/11196b944823/41467_2019_9652_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd3e/6458119/0a184c0a54b8/41467_2019_9652_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd3e/6458119/9aa9e553cb1c/41467_2019_9652_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd3e/6458119/3764e6238308/41467_2019_9652_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd3e/6458119/11196b944823/41467_2019_9652_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd3e/6458119/0a184c0a54b8/41467_2019_9652_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fd3e/6458119/9aa9e553cb1c/41467_2019_9652_Fig4_HTML.jpg

相似文献

1
Age-specific differences in the dynamics of protective immunity to influenza.流感保护性免疫的动态在年龄特异性方面的差异。
Nat Commun. 2019 Apr 10;10(1):1660. doi: 10.1038/s41467-019-09652-6.
2
Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.神经氨酸酶抑制抗体滴度与对同一神经氨酸酶亚型的异源流感病毒株的保护作用相关。
J Virol. 2018 Aug 16;92(17). doi: 10.1128/JVI.01006-18. Print 2018 Sep 1.
3
Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults.流感病毒感染可诱导儿童产生狭窄的抗体反应,但可诱导成人产生广泛的回忆反应。
mBio. 2020 Jan 21;11(1):e03243-19. doi: 10.1128/mBio.03243-19.
4
Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.2009年甲型H1N1流感大流行感染后儿童和成人对流感病毒的交叉反应性免疫。
Antiviral Res. 2015 Feb;114:106-12. doi: 10.1016/j.antiviral.2014.12.008. Epub 2014 Dec 13.
5
Universal influenza vaccines, science fiction or soon reality?通用流感疫苗,是科幻小说还是即将成为现实?
Expert Rev Vaccines. 2015;14(10):1299-301. doi: 10.1586/14760584.2015.1060860. Epub 2015 Jun 23.
6
Quantifying Protection Against Influenza Virus Infection Measured by Hemagglutination-inhibition Assays in Vaccine Trials.在疫苗试验中通过血凝抑制试验测定流感病毒感染防护效果的量化评估
Epidemiology. 2016 Jan;27(1):143-51. doi: 10.1097/EDE.0000000000000402.
7
Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.新型 H3 特异性广谱中和单克隆抗体的鉴定 该抗体靶向血凝素球状头部,来源于一位具有广泛血清学反应性的流感病毒免疫供者
J Virol. 2020 Feb 28;94(6). doi: 10.1128/JVI.01035-19.
8
Seroconversion to seasonal influenza viruses after A(H1N1)pdm09 virus infection, Quebec, Canada.感染 A(H1N1)pdm09 病毒后季节性流感病毒的血清转化,加拿大魁北克省。
Emerg Infect Dis. 2012 Jul;18(7):1132-4. doi: 10.3201/eid1807.111680.
9
Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains.针对当前甲型H1N1流感疫苗毒株的抗体并不能保护某些个体免受当代流行的甲型H1N1流感病毒毒株的感染。
J Infect Dis. 2016 Dec 15;214(12):1947-1951. doi: 10.1093/infdis/jiw479. Epub 2016 Oct 7.
10
Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.健康志愿者体内针对大流行的A/加利福尼亚/07/2009(H1N1)流感病毒的血清型特异性或交叉反应性神经氨酸酶抑制抗体。
BMC Res Notes. 2015 Apr 10;8:136. doi: 10.1186/s13104-015-1086-z.

引用本文的文献

1
High-resolution antibody dynamics following influenza vaccination reveal predominantly weak responses as well as infrequent but durable immunity across the 2014-2022 seasons.流感疫苗接种后的高分辨率抗体动力学显示,在2014 - 2022年季节期间,主要是弱反应以及罕见但持久的免疫力。
Vaccine. 2025 Sep 12:127677. doi: 10.1016/j.vaccine.2025.127677.
2
Pleiotropic mutational effects on function and stability constrain the antigenic evolution of influenza hemagglutinin.对功能和稳定性的多效性突变效应限制了流感血凝素的抗原进化。
bioRxiv. 2025 May 24:2025.05.24.655919. doi: 10.1101/2025.05.24.655919.
3
Mathematical Modeling of Influenza Dynamics: Integrating Seasonality and Gradual Waning Immunity.

本文引用的文献

1
Influenza Hemagglutination-inhibition Antibody Titer as a Mediator of Vaccine-induced Protection for Influenza B.流感 B 型疫苗诱导保护作用的中介:血凝抑制抗体滴度
Clin Infect Dis. 2019 May 2;68(10):1713-1717. doi: 10.1093/cid/ciy759.
2
Timescales of influenza A/H3N2 antibody dynamics.甲型 H3N2 流感抗体动态的时间尺度。
PLoS Biol. 2018 Aug 20;16(8):e2004974. doi: 10.1371/journal.pbio.2004974. eCollection 2018 Aug.
3
Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999-2014.
流感动态的数学建模:整合季节性和逐渐减弱的免疫力
Bull Math Biol. 2025 May 16;87(6):75. doi: 10.1007/s11538-025-01454-w.
4
A 14-year influenza reinfection surveillance in Chongqing, China: A retrospective analysis.中国重庆14年流感再感染监测:一项回顾性分析。
Hum Vaccin Immunother. 2025 Dec;21(1):2497576. doi: 10.1080/21645515.2025.2497576. Epub 2025 May 5.
5
High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains.高通量中和测量与人类流感毒株的进化成功密切相关。
bioRxiv. 2025 Mar 12:2025.03.04.641544. doi: 10.1101/2025.03.04.641544.
6
How immunity shapes the long-term dynamics of influenza H3N2.免疫力如何塑造甲型H3N2流感病毒的长期动态变化。
PLoS Comput Biol. 2025 Mar 20;21(3):e1012893. doi: 10.1371/journal.pcbi.1012893. eCollection 2025 Mar.
7
Characterizing the Short- and Long-Term Temporal Dynamics of Antibody Responses to Influenza Vaccination.流感疫苗接种抗体反应的短期和长期时间动态特征分析。
medRxiv. 2025 Feb 27:2025.02.26.25322965. doi: 10.1101/2025.02.26.25322965.
8
A path toward developing a universal mucosal influenza vaccine: An upside-down influenza HA vaccine based on extracellular vesicles.开发通用黏膜流感疫苗的途径:基于细胞外囊泡的倒置流感血凝素疫苗。
Mol Ther. 2025 Feb 5;33(2):432-434. doi: 10.1016/j.ymthe.2025.01.003. Epub 2025 Jan 24.
9
Antibody responses against influenza A decline with successive years of annual influenza vaccination.随着每年接种流感疫苗的年份增加,针对甲型流感的抗体反应会下降。
NPJ Vaccines. 2025 Jan 17;10(1):11. doi: 10.1038/s41541-024-01057-x.
10
Durability of Adaptive Immunity in Immunocompetent and Immunocompromised Patients Across Different Respiratory Viruses: RSV, Influenza, and SARS-CoV-2.免疫功能正常和免疫功能低下患者针对不同呼吸道病毒(呼吸道合胞病毒、流感病毒和严重急性呼吸综合征冠状病毒2)的适应性免疫持久性
Vaccines (Basel). 2024 Dec 22;12(12):1444. doi: 10.3390/vaccines12121444.
利用 1999-2014 年 29 个国家基于病例的全球监测数据按年龄分布的流感病毒类型。
BMC Infect Dis. 2018 Jun 8;18(1):269. doi: 10.1186/s12879-018-3181-y.
4
Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies.人类流感感染诱导广泛交叉反应和保护性神经氨酸酶反应性抗体。
Cell. 2018 Apr 5;173(2):417-429.e10. doi: 10.1016/j.cell.2018.03.030.
5
Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A/H1N1pdm Virus.评估健康志愿者挑战甲型流感病毒 A/H1N1pdm 时预先存在的抗血凝素茎部抗体作为保护相关性。
mBio. 2018 Jan 23;9(1):e02284-17. doi: 10.1128/mBio.02284-17.
6
Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic.大流行悖论:H2N2 大流行流感早期感染增加了 2009 年 H1N1 大流行期间的死亡易感性。
mBio. 2018 Jan 16;9(1):e02091-17. doi: 10.1128/mBio.02091-17.
7
Individual and Population Trajectories of Influenza Antibody Titers Over Multiple Seasons in a Tropical Country.个体和人群在热带国家多个季节中流感抗体效价的变化轨迹。
Am J Epidemiol. 2018 Jan 1;187(1):135-143. doi: 10.1093/aje/kwx201.
8
Seasonal Incidence of Symptomatic Influenza in the United States.美国季节性流感的发病情况。
Clin Infect Dis. 2018 May 2;66(10):1511-1518. doi: 10.1093/cid/cix1060.
9
Evolution-informed forecasting of seasonal influenza A (H3N2).基于进化信息的季节性流感 A(H3N2)预测。
Sci Transl Med. 2017 Oct 25;9(413). doi: 10.1126/scitranslmed.aan5325.
10
Monte Carlo profile confidence intervals for dynamic systems.动态系统的蒙特卡洛轮廓置信区间
J R Soc Interface. 2017 Jul;14(132). doi: 10.1098/rsif.2017.0126.